Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
241.67
+4.34 (1.83%)
At close: Jun 26, 2026, 4:00 PM EDT
246.64
+4.97 (2.06%)
After-hours: Jun 26, 2026, 7:11 PM EDT
Axsome Therapeutics Employees
Axsome Therapeutics had 925 employees as of December 31, 2025. The number of employees increased by 242 or 35.43% compared to the previous year.
Employees
925
Change (1Y)
242
Growth (1Y)
35.43%
Revenue / Employee
$580,521
Profits / Employee
-$154,347
Market Cap
12.44B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Jazz Pharmaceuticals | 2,890 |
| Ionis Pharmaceuticals | 1,402 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
| BridgeBio Pharma | 839 |
| Arrowhead Pharmaceuticals | 711 |
AXSM News
- 19 hours ago - Axsome Therapeutics doses first patient in FOCUS-3 trial - TheFly
- 19 hours ago - Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) - GlobeNewsWire
- 8 days ago - Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month - GlobeNewsWire
- 9 days ago - Axsome Therapeutics price target raised to $300 from $275 at TD Cowen - TheFly
- 11 days ago - Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026 - GlobeNewsWire
- 18 days ago - Axsome Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Axsome Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 22 days ago - Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting - GlobeNewsWire